Status: Recruiting
Tenapanor in Synucleinopathy-Related Constipation
Investigation of tenapanor as a potential treatment for synucleinopathy-associated constipation
Participants needed: 30
Trial details
Phase: Phase 2Age: 50-89Biological sex: AllType: InterventionalSponsor: Cedar Valley Digestive Health CenterUpdated: Feb 10, 2025Locations: 1
Eligibility criteria
Age 50-89 years. [+4]
Functional diarrhea or IBS-D/M based on Rome IV Criteria. [+4]